Tenax Therapeutics
TENX
5 hedge funds and large institutions have $926K invested in Tenax Therapeutics in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
16% less capital invested
Capital invested by funds: $1.1M → $926K (-$170K)
17% less funds holding
Funds holding: 6 → 5 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$28.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$9.44K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5K |
| 3 |
PCIA
Prime Capital Investment Advisors
Overland Park,
Kansas
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $461K | +$28.3K | +3 | +6% |
|
|
FWP
2
FAS Wealth Partners
Leawood,
Kansas
| $308K | – | – | – |
|
3
Dimensional Fund Advisors
Austin,
Texas
| $77K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $65K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $12K | -$9.44K | -1 | -50% |
|
6
BlackRock
New York
| $3K | – | – | – |
|
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$5K | -1 | Closed |
|
|
PCIA
8
Prime Capital Investment Advisors
Overland Park,
Kansas
| – | -$1K | – | – |
|
TENX Hedge Fund Activity: Q3 2018 in Review
5 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2018, worth a combined $926K — down 16% from $1.1M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TENX and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $28.3K. The largest seller was UBS Group, cutting an estimated $9.44K.
- 5 institutional investors held Tenax Therapeutics (TENX) as of Q3 2018, down from 6 in Q2 2018.
- Funds reported $926K of Tenax Therapeutics stock for Q3 2018, down 16% quarter-over-quarter.
- 0 funds opened new Tenax Therapeutics positions in Q3 2018 and 1 closed out, a net change of -1 holder.
- The largest Tenax Therapeutics buyer in Q3 2018 was Renaissance Technologies, an estimated $28.3K added.
- The largest Tenax Therapeutics seller in Q3 2018 was UBS Group, an estimated $9.44K sold.
Based on aggregated 13F filings for Q3 2018.